Key Takeaways
- Record order book, uneven conversion: Order backlog hit an all-time high of ₹2,810 crore with a book-to-bill over 1.6x, but revenue growth of 26.5% YoY lagged the order intake pace because of material availability challenges and customer-site delays.
- Margins dipped on deliberate investment: EBITDA margin fell 135 bps YoY to 8.7%, driven entirely by a 100–150 bps load from a fully-staffed sales engine and expensed product development costs, while gross and contribution margins actually improved.
- The B2S pipeline is a FY30 story: Four build-to-spec programs carry a combined ~$1 billion value over 7–9 years, but production and meaningful revenue conversion are not expected until FY30, making this a visibility asset rather than a near-term growth driver.
- Sales cost absorption is the margin lever: Management has front-loaded sales and marketing spend and will not add more until quarterly revenue at least doubles, so FY28 margin expansion hinges on operating leverage from revenue growth absorbing those already-loaded costs.
- What to watch next quarter: Whether order intake sustains above ₹600 crore, any improvement in material availability that unlocks faster revenue conversion, and the pace at which the 9–10% FY27 margin commitment firms up toward the higher end.
Order Book & Revenue Conversion
- Order book momentum: Six consecutive quarters of positive momentum pushed the backlog to a record ₹2,810 crore, with order intake close to ₹600 crore-plus in each of the last two quarters and a book-to-bill exceeding 1.6x in Q2.
- Pipeline depth: The visible pipeline exceeds $1 billion, and management expects roughly 40% of it to convert, implying $400 million to $500 million in potential order intake.
- Conversion gap: Revenue grew 26.5% YoY to ₹393.1 crore, below the order book growth rate, because material availability challenges and some customer-site delays slowed execution; the existing backlog will take 18–24 months to convert.
- H2 growth expectation: Management expects 30–35% full-year revenue growth, with H2 definitely above 30%, implying a pickup in conversion as material headwinds ease.
Krishna Bodanapu: "The continued strength of our order book and sales pipeline. ... order backlog now stands at INR2,813 crores with -- on top of which there is a pipeline which is in excess of $1 billion."
Segment Performance & Mix Shift
| Segment | Revenue Share | YoY Growth | Commentary |
|---|---|---|---|
| Aerospace | 47% | ▲ 62% | Strongest growth driver; sustained demand from large OEMs. |
| Industrial | 31% | ▲ 29% | Solid growth alongside aerospace. |
| Defense | 7% | ▲ 13% | Continued traction. |
| Medtech | 14% | ▲ 14% | Steady contribution. |
- Box build surge: Revenue from box build, a more integrated offering beyond component-level manufacturing, grew 85–86% YoY and now contributes 27% of revenue, signaling progression up the value chain.
- PCBA remains the base: PCBA grew 19% YoY and still accounts for 48% of revenue, the largest single category.
- Geographic concentration: International markets contributed 93% of revenue, with India at 7%, supported by demand from aerospace, medical and industrial customers.
- New customer adds: Three new logos were added in Q2, and the Altek integration, now renamed Cyient DLM Electronics, Inc., is performing to plan with a sales team on the ground in the US pursuing further growth.
Margin Mechanics
- Q2 margin walk: EBITDA margin fell 135 bps YoY to 8.7%, driven by two factors: a fully-loaded sales and marketing cost base that added 150–200 bps of cost versus last year when similar revenue was done without it, and ongoing product development spend that is expensed rather than capitalized.
- Underlying quality improved: Gross margin and contribution margin are significantly higher in FY27 year-to-date than in FY26, so the reported margin compression is an absorption problem, not a deterioration in business quality.
- H1 stability: Despite the Q2 dip, H1 EBITDA margin remained broadly stable at 9.6%, and normalized PAT grew 60.4% YoY to ₹32.1 crore.
- Finance cost tailwind: Finance costs declined 21% YoY in H1, supported by lower working capital borrowings, and net working capital improved sequentially from 161 days to 153 days.
- The absorption bet: Management stated it will not add any net new sales and marketing costs until quarterly revenue at least doubles; the cost base is now fully loaded, so revenue growth in FY28 will drive margin expansion purely through absorption.
Krishna Bodanapu: "It's a point-in-time issue that's fully loaded... there's zero absorption right now because if you look at it last year, we would have done a similar revenue with none of that cost, which is almost 150, 200 basis points."
Build-to-Spec / Electronic Products
- Rebranded and reframed: The build-to-specification offering has been renamed "electronic products" to reflect broader value across the product life cycle, and four major programs are now in the design and testing phase.
- $1 billion pipeline, FY30 payoff: The four programs carry a combined value close to $1 billion over 7–9 years, with some contracts already signed and others to be signed at a later stage; production ramp-up and meaningful revenue are expected from FY30 onwards.
- eVTOL program: Contracts are signed but not yet in the order book; production is expected in FY29, with revenues probably beginning that year.
- Honeywell program: A build-to-print engagement where prototypes have been made and are in testing with engineering changes; the path to serial production has taken some time.
- No near-term revenue: Management was explicit that these programs will drive "significant sustained growth from FY30 onwards," making them a visibility and strategic asset rather than a contributor to the FY27–FY28 growth algorithm.
Rajendra Velagapudi: "the contracts, we know that what are the volumes are going to be there, what is the -- I mean the value of the contract is going to be. That's where I said it is $1 billion."
Long-Term Strategy & New Growth Vectors
- Three-phase roadmap: Phase 1 (strengthen) deepens the four core industries with a 9–11% margin framework; Phase 2 (expand, FY27–FY29) adds robotics and AI data center as key growth areas and sharpens focus on semiconductor capital equipment with an 11–13% margin framework; Phase 3 (transform, FY30 onward) builds a differentiated product and platform moat targeting 13–18% margins.
- Semiconductor capital equipment: Already generating revenue in the last two quarters, with a ramp-up expected going forward.
- AI data centers and robotics: Exploration has just begun; management will share an update by the end of the financial year, with no material contribution implied in the near term.
- Sales leadership built out: The company has added salespeople, bid resources, marketing costs, and a Chief Growth Officer, positioning the cost base ahead of the revenue curve for the expansion phase.
Rajendra Velagapudi: "The margin framework for this phase is approximately some 13% to 18%, reflecting a growing contribution from product platforms and intellectual property-led differentiation."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FY27 revenue growth | 30–35% full-year growth; H2 definitely above 30% | FY27 |
| FY27 EBITDA margin | High single-digit, close to ~9%, in the 9–10% range | FY27 |
| FY28 EBITDA margin | Double-digit from Q1 FY28 onwards (~11% per an analyst's math) | FY28 |
| Order intake | ₹600 crore-plus per quarter for next two quarters | Q3 and Q4 FY27 |
| Sales & marketing cost | No net new additions until quarterly revenue at least doubles | Condition-based |
| B2S / electronic products revenue | Significant sustained growth from production ramp-up | FY30 onwards |
| eVTOL program revenue | Production expected FY29, revenues from FY29 | FY29 |
| AI data center and robotics update | Management to share update | By end of FY27 |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Revenue | ₹393.1 crore, +26.5% YoY |
| H1 FY27 revenue | ₹766.9 crore, +30.2% YoY |
| EBITDA | ₹34.2 crore, +9.5% YoY |
| EBITDA margin | 8.7%, down 135 bps YoY from 10.0% |
| H1 FY27 EBITDA margin | 9.6%, broadly stable YoY |
| Normalized PAT | ₹15.8 crore, +25.8% YoY |
| Normalized PAT margin | 4.0%, stable YoY |
| Reported PAT | ₹34 crore, includes ₹18.2 crore one-time earn-out reversal |
| H1 FY27 normalized PAT | ₹32.1 crore, +60% YoY |
| FY27 EBITDA margin guidance | 9% to 10%; higher end of single-digit range |
| FY28 onwards EBITDA margin guidance | Double-digit |
| Order backlog | ₹2,813 crore, all-time high; +₹210 crore QoQ and +₹520 crore YoY |
| Book-to-bill ratio | Over 1.6x |
| Bid pipeline | In excess of $1 billion |
| Win ratio from pipeline | Close to around 40% |
| Order book execution timeline | 18 to 24 months, very few beyond 2 years |
| Aerospace revenue | 47% of revenue, +62% YoY |
| Industrial revenue | 31% of revenue, +29% YoY |
| Defense revenue | 7% of revenue, +13% YoY |
| Medtech revenue | 14% of revenue, +14% YoY |
| PCBA revenue | 48% of revenue, +19% YoY |
| Box build revenue | 27% of revenue, +86% YoY |
| International revenue | 93% of revenue; India 7% |
| New logos added | 3 |
| Net working capital | 153 days, improved from 161 days in Q1 |
| Inventory days | 162 days, stable |
| DSO | 73 days, improved from 77 days in Q1 |
| DPO | 68 days, increased from 63 days in Q1 |
| Operating free cash flow | ₹17.2 crore |
| Finance costs | ₹6.1 crore, declined 10.4% YoY |
| Build-to-spec electronic products pipeline | Close to $1 billion across 4 programs, 7–9 year duration, not yet in order book |
| Margin impact from investments | 100 to 150 bps in Q2 |